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K e y  M e s s a g e s 
1. The natural COOH-terminal truncated HBx 
was more frequently detected in hepatocellular 
carcinoma (HCC) in male than female patients.
2. There was no significant clinicopathological 
correlation with the HBx status or remarkable 
changes in androgen receptor (AR) expression in 
the presence of different truncated HBx mutants 
compared with full-length HBx. 
3. Lower expression of AR was associated with 
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Introduction
Hepatocellular carcinoma (HCC) is especially 
prevalent in Hong Kong due to prevalent hepatitis 
B virus (HBV) infection. HBV-associated HCC has 
a male predominance, with a male-to-female ratio of 
about 4-5:1. This is in contrast to HCV-associated 
HCC that has a male-to-female ratio of 1.5-2:1. HBV 
is a partially double-stranded DNA virus containing 
four overlapping open reading frames. Among 
them, the X gene is most frequently integrated into 
the host genome naturally. Naturally integrated X 
gene is frequently found to be deleted at the 3’-end, 
leading to COOH-terminal truncated HBx protein. 
 In our previous study, we showed that in HBV-
positive patients with HCC, full-length HBx (HBxFL) 
was detected in all non-tumourous livers (n=51). 
However, HBxFL (HBx 1-154 amino acids) was 
found in only 53% of the tumours, whereas natural 
COOH-truncated HBx (HBx 1-130 amino acids) was 
found in the remaining 47%. The presence of natural 
COOH-truncated HBx significantly correlated with 
the presence of venous invasion (P<0.01), a hallmark 
of metastasis, suggesting COOH-truncation of HBx 
plays a significant role in enhancing cell invasiveness 
and metastasis in HCC.1 In addition, HBx mutants 
with different COOH-truncated length cause HCC 
by altering intracellular distribution and consecutive 
modulation of the important proliferative STAT/
SOCS signalling, indicating a role of various shorter 
HBx mutants in tumourigenesis.2 The mislocalisation 
of HBx truncated mutants can be explained in part 
by the finding that HBx protein contains a functional 
nuclear export sequence from amino acids 89 to 100.3 
Therefore, the COOH-terminal truncated form of 
HBx has been demonstrated to play a tumourigenic 
role in HCC and its oncogenicity may vary according 
to the truncated length.
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 Among male HBV carriers, the risk of HCC 
development is significantly increased in those 
with higher androgen receptor (AR) activity. HBV 
infection may, therefore, particularly cooperate 
with male-specific AR signalling to accelerate 
hepatocarcinogenesis. Moreover, HBx has been 
shown to enhance AR transcriptional activity 
through GSK-3β kinase pathways.4 However, no 
report has shown a correlation between AR signalling 
and COOH-terminal truncated HBx protein.
 In this study, we hypothesised that HBx 
cooperated with male-specific AR signalling to 
enhance hepatocarcinogenesis, and natural HBx 
truncated mutants had different effects on this AR 
signalling. The prevalence of natural COOH-terminal 
truncated HBx mutants (HBx ∆C1 and HBx <∆C1) 
was slightly higher in male than female with HCC, 
but no significant clinicopathological association was 
observed with the expression of COOH-terminal 
truncated HBx mutants in HCCs. The COOH-
terminal truncated HBx mutants were not associated 
with the mRNA expression of AR in the same HCC 
specimens, but the mRNA expression of AR showed 
a significant correlation with the metastatic potential, 
cellular differentiation and staging of HCC.
Methods
This study was conducted from April 2013 to April 
2014.
Patient samples
A total of 99 pairs of human HCCs from patients 
who underwent liver resection for HCC between 
1992 and 2001 at Queen Mary Hospital, Hong Kong, 
were selected. All these 99 patients (77 men and 22 
women) aged 19 to 74 years were positive for serum 
hepatitis B surface antigen (HBsAg). All specimens 
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more aggressive tumour phenotype and a higher 
metastatic potential of HCC.
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were snap-frozen in liquid nitrogen and kept at 
-80ºC. Frozen sections were cut from HCC blocks 
separately and stained for histological examination 
to ensure a homogenous cell population of tissues. 
RNA extraction and reverse-transcriptase 
polymerase chain reaction
Total RNA was isolated using TRIZOL reagent 
(Invitrogen, Carlsbad [CA], USA) following the 
manufacturer’s instructions. cDNA was synthesised 
by using Gold RNA PCR Core Kit (Applied 
Biosystems, Foster City [CA], USA) following the 
manufacturer’s instructions.
Semi-quantitative PCR
For semi-quantitative PCR, the reaction was set up 
using AmpliTaqGOLD enzyme (Applied Biosystems, 
Carlsbad [CA], USA) and carried out with Takara 
PCR Thermal Cycler. PCR products were detected by 
1.5% ethidium bromide-agarose gel electrophoresis 
at 100V for 15 minutes and visualised on a gel 
documentation system. The primers for PCR were 
as follows: HBx ATG: 5’-CCC AAG CTT ATG GCT 
GCT AGG CTG TGC T-3’; HBx full length (HBxFL): 
5’-CGA ATT CTT AGG CAG AGG TGA AAA AGT 
TG-‘; HBx ∆C1: 5’-CGA ATT CTT ACT TTA ATC 
TAA TCT CCT CCC C-3’; HBx <∆C1: 5’- CTT ATG 
TAA GAC CTT GGG CAA CAT-3’
Quantitative real-time PCR
The reaction was set up using SYBR Green Real-
Time PCR Master Mixes (Applied Biosystems) and 
was carried out with Applied Biosystems 7900 HT 
Fast Real-Time PCR System (Applied Biosystems) 
according to the manufacturer’s protocol. All 
reactions were performed in triplicate and the 
expression of targeted gene relative to hypoxanthine 
guanine phosphoribosyl transferase was determined 
using 2–∆CT method. The primer sequences for 
real-time PCR were as follows: AR F: 5’-CTC 
ACC AAG CTC CTG GAC TC-3’; AR R: 5’-GAA 
AGG ATC TTG GGC ACT TG-3’; HPRT F:5’- 
CTTTGCTGACCTGCTGGATT-3’; HPRT R:5’-
CTGCATTGTTTTGCCAGTGT -3’.
Results
The prevalence of natural COOH-terminal 
truncated HBx mutants (HBx ∆C1 and HBx 
<∆C1) was slightly higher in HCCs from 
male than female patients
The HCCs were screened for the presence of 
COOH-terminal truncated HBx mutants, ∆C1 (HBx 
1-130 amino acids) and <∆C1 (HBx 1-95 amino 
acids). The expression pattern of the truncated HBx 
mutants between male and female patients was 
compared. Among the 99 HCC samples, the natural 
COOH-terminal truncated HBx mutants (HBx ∆C1 
and HBx <∆C1) were more frequently detected in 
HCCs in males than females (44% vs 37%, Fig 2). 
The frequency of HBx ∆C1 in HCCs in males was 
similar to that in females (30% vs 32%), but a more 
remarkable difference was observed for HBx <∆C1 
mutants (14% vs 5%, Fig 1). These indicated that the 
COOH-terminal truncated HBx mutants that are 
shorter than ∆C1 may be found more frequently in 
male HCCs and may be more associated than HBx 
∆C1 with the male predominance in HCC. 
The expression of COOH-terminal truncated 
HBx mutants in human HCCs showed no 
significant clinicopathological or survival 
correlation
To examine whether the presence of natural COOH-
terminal truncated HBx mutants was associated 
with a particular tumour biological behaviour and 
consequent prognosis, the expression of full-length 
HBx and truncated HBx mutants was correlated with 
different clinicopathological features and survival 
rates in the 99 HCC patients. The presence of COOH-
terminal truncated HBx mutants (ie the group with 
either HBx ∆C1 or HBx<∆C1) did not show any 
significant correlation with the clinicopathological 
features (Fig 2a). In addition, there was no significant 
FIG 1.  The frequency of presence of HBx FL and COOH-
terminal truncated HBx∆C1 and ∆<C1 in male and female 
HBV-associated HCCs (n=99). Presence of HBx FL and 
COOH-terminal truncated HBx mutants was detected by 
conventional PCR. The frequency of COOH-truncated mutants 
was higher in male than female HCC patients.
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difference between the presence of HBx mutants 
and the disease free or overall survival (Fig 2b). This 
demonstrated that the presence of COOH-terminal 
truncated HBx mutants might not be associated 
with tumour biological behaviour. 
The COOH-terminal truncated HBx mutants 
had no significant correlation with the mRNA 
expression of AR in the same HCC specimens
To investigate the effect of different COOH-terminal 
truncated HBx mutants on the mRNA expression 
level of AR, the expression level of AR was examined 
and correlated with the presence of COOH-terminal 
truncated HBx mutants in the 99 HCCs. There was 
no significant difference between the mRNA levels of 
AR and the presence of COOH-terminal truncated 
HBx mutants or the full-length HBx (Fig 3a). 
Although there was a trend of association between 
the presence of HBx∆C1 and downregulation of 
AR (P=0.4358), the mRNA levels of AR were not 
significantly different upon further stratification of the 
HBx mutants into HBx∆C1 and HBx<∆C1 (Fig 3b). 
These indicated that the COOH-terminal truncated 
HBx mutants, either HBx ∆C1 or HBx<∆C1, may not 
regulate mRNA expression of AR. 
The mRNA expression of AR showed a 
significant correlation with the metastatic 
potential, cellular differentiation and staging 
of HCC
To evaluate the association of the mRNA expression 
of AR with a particular tumour biological 
behaviour and prognostic significance in HCC, 
the mRNA levels of AR correlated with different 
clinicopathological features. Lower expression of 
AR in the HCC was associated with the presence 
of tumour venous invasion (P=0.0213), tumour 
microsatellite formation (P=0.0251), poorer tumour 
cellular differentiation (P=0.0002) and higher 
tumour stage (P=0.0073) [Fig 3c]. This correlation 
FIG 2.  (a) Correlation between HBx status (FL vs ∆C1 &<∆C1) and various clinicopathological parameters. (b) Correlation of 
the overall survival and disease free survival rates of HCC patients with HBx FL and ∆C1&<∆C1.
Clinicopathological features FL HBx status∆C1 & <∆C1 P value
Gender MaleFemale
44
14
33
8 0.632
Tumour size ≤5 cm>5 cm
23
25
10
30 0.192
Tumour cellular differentiation
(Edmondson's grading)
Better (I-III)
Poorer (IV-VI)
26
31
19
22 1.000
Tumour encapsulation AbsentPresent
35
22
28
13 0.537
Tumour microsatellite AbsentPresent
27
31
24
21 0.841
Direct liver invasion AbsentPresent
39
16
23
16 0.272
Venous invasion AbsentPresent
29
29
16
25 0.311
Tumour stage Stage I-IIStage II-IV
22
34
15
26 0.836
∆C1 & <∆C1
FL
∆C1 & <∆C1-censored
FL-censored
0 50 100 150 200 250
Overall survival (months)
1.0
0.8
0.6
0.4
0.2
0
C
um
ul
at
iv
e 
su
rv
iv
al
P=0.857
0 20 40 60 80 100 120 140
Disease-free survival (months)
1.0
0.8
0.6
0.4
0.2
0
C
um
ul
at
iv
e 
su
rv
iv
al
P=0.346
(a)
(b)
  #  Chiu and Ng #
46 Hong Kong Med J  ⎥  Volume 22 Number 3 (Supplement 4)  ⎥  June 2016  ⎥  www.hkmj.org Hong Kong Med J  ⎥  Volume 22 Number 3 (Supplement 4)  ⎥  June 2016  ⎥  www.hkmj.org
FIG 3.  (a, b) The AR mRNA levels were correlated with the presence of HBxFL and different COOH-terminal truncated 
HBx mutants in human HBV-associated HCC tissues (n=99). (c) The mRNA expression of AR was correlated with different 
tumour biological features including presence of tumour venous invasion, tumour encapsulation, direct liver invasion, tumour 
microsatellite formation, tumour cellular differentiation, tumour size, background liver disease, gender and tumour staging. Lower 
expression of AR was associated with the presence of venous invasion, microsatellite formation, poorer cellular differentiation 
and higher tumour stage in HCC.
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study demonstrated that lower expression of AR was 
associated with a higher metastatic potential and 
more aggressive tumour phenotype in HCC. 
Discussion
The frequency of natural COOH-terminal truncated 
HBx (HBx ∆C1 and HBx<∆C1) was higher in HCCs 
of male than female patients (44% vs 37%). More 
importantly, when the mutants were stratified into 
the group with HBx<∆C1 only and the other one with 
HBx FL orHBx ∆C1, the frequency of HBx mutants 
in male and female HCCs (14% vs 5%) was even more 
obvious. With a higher frequency of HBx<∆C1 in 
HCCs of males and the differential regulatory roles 
of shorter truncated HBx mutants in HCC due to 
nuclear mislocalisation,2 these imply that HBx<C1 
may play a role in hepatocarcinogenesis in male 
HCC patients and may contribute in part to the male 
predominance of HCC. Nonetheless, the underlying 
mechanisms require further investigation. In 
addition, the expression status of HBx in the 
HCCs showed no significant correlation with any 
clinicopathological features or patient survival. This 
might have been a result of technical limitations 
in examining HBx gene truncation, where the co-
existence of HBx FL and COOH-terminal truncated 
mutants in the same specimen cannot be detected 
by conventional PCR. The HCC tumours with HBx 
FL detected might also harbour HBx∆C1 and/or 
HBx<∆C1, and this may influence the comparison 
among groups of various parameters.
 Full-length HBx protein has been shown 
to enhance AR transcriptional activity through 
modulation of c-Src and GSK-3β kinase pathways.5 
In addition, HBx protein enhances AR-responsive 
gene expression depending on androgen level.6 
Therefore, the regulatory roles of full-length HBx 
on AR activity are well demonstrated. In the present 
study, we examined the consequence of COOH-
terminal truncated HBx on AR transactivation. The 
results showed no significant correlation between 
the presence of X truncation and mRNA expression 
of AR in HCCs when compared with the full-length 
HBx, suggesting that COOH-truncated HBx mutants 
may not exert a more potent activation on AR than 
the full-length HBx. Nevertheless, a lower expression 
of AR was associated with more aggressive tumour 
behaviour. This finding was consistent with that in 
other studies that report hepatic AR suppression 
of HCC metastasis through modulation of cell 
migration and anoikis,7 enhanced cell adhesion and 
decreased cell migration via modulating β1-integrin-
AKT signalling in HCC cells.8 In contrast to our 
results, several reports found that the activation and 
overexpression of AR promoted cell invasion and 
migration in HCC and tumour staging.9 Therefore, 
the potential roles of AR in hepatocarcinogenesis 
remain elusive and warrant further investigation.
Conclusion
The HBx truncated mutants are more frequent in 
HCCs of males than females, and this may implicate 
a role of HBx truncated mutants in the male 
predominance of HCC. Nonetheless, the correlation 
study of the presence of HBxC1 or HBx<∆C1 and 
the different clinicopathological features of HCC 
patients and the mRNA levels of AR implied that 
HBx truncated mutants alone may not exert a 
significant effect on the tumour biological behaviour 
or induce a more potent transactivation of AR than 
HBxFL. AR may play a role in hepatocarcinogenesis, 
in which lower expression of AR is associated with 
more aggressive tumour phenotype and a higher 
metastatic potential of HCC.
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